|Reference : La stromelysine-1 en pathologie inflammatoire: signification, specificite et elements...|
|Scientific journals : Article|
|Human health sciences : Rheumatology|
|La stromelysine-1 en pathologie inflammatoire: signification, specificite et elements de regulation|
|[en] stromelysin-1 in inflammatory disease: significance, specificity, and regulation elements|
|Ribbens, Clio [Centre Hospitalier Universitaire de Liège - CHU > > Rhumatologie >]|
|Malaise, Michel [Université de Liège - ULg > Département des sciences cliniques > Rhumatologie >]|
|Bulletin et Mémoires de l'Académie Royale de Médecine de Belgique|
|Académie Royale de Médecine de Belgique|
|275-281, discussion 281-283|
|Yes (verified by ORBi)|
|[en] cytokines ; Arthritis|
|[en] Stromelysin-1 or matrix metalloproteinase-3 (MMP-3) is a key enzyme of the degradation of the extracellular matrix in rheumatoid arthritis. MMP-3 is indeed induced by pro-inflammatory cytokines and may in turn activate other metalloproteinases. MMP-3 is a synovial parameter reflecting the local inflammatory reaction induced by inflammatory cytokines. It is not specific for rheumatoid arthritis nor for the erosive capacity of an arthropathy, which does not exclude its role in articular degradation. Serum MMP-3 is increased in diseases characterized by synovitis but also by steroid therapy. Although it is not disease-specific, serum MMP-3 could be useful as a synovial-derived marker of local inflammation in rheumatoid arthritis, in parallel to CRP which is a systemic marker of inflammation. Furthermore, early determination of serum MMP-3 could constitute a new tool predictive of the disease activity and the therapeutic response in rheumatoid arthritis.|
|Researchers ; Professionals|
There is no file associated with this reference.
All documents in ORBi are protected by a user license.